Skip to main content
Filing year 2023

ALZHEIMER'S DRUG DISCOVERY FOUNDATION

New York, New York·EIN 20-1082179·NTEE V36 · Social Science·501(c)(3)
Total revenue
$37.7M
Total assets
$324.2M
Total expenses
$61.9M
Reported officers
30
Mission

ACCELERATE THE DISCOVERY OF DRUGS TO PREVENT, TREAT AND CURE ALZHEIMER'S DISEASE AND RELATED DEMENTIAS.

Executive compensation, broken down

Form 990 · Part VII & Schedule J · 8 reported individuals · Filing year 2023

Percentile bands compare each position's total pay with the same role at Social Science organizations nationwide.

Founding Exec. Dir. & Chief Sci. Off.
Officer (Unspecified)
$665k
$746k
Base
$616k
Bonus
Other
$16k
Benefits
$26k
CEO
Above 90th percentile
$659k
$740k
Base
$616k
Bonus
Other
$3k
Benefits
$26k
Executive Director, Drug Dev.
75th to 90th percentile
$467k
$524k
Base
$431k
Bonus
Other
$3k
Benefits
$19k
CFO and Head of Mission
Above 90th percentile
$391k
$439k
Base
$334k
Bonus
$30k
Other
$3k
Benefits
$12k
Chief External Affairs
Highest Compensated Employee
Above 90th percentile
$372k
$417k
Base
$359k
Bonus
Other
$720
Benefits
Head of Search and Evaluation
Highest Compensated Employee
Above 90th percentile
$350k
$393k
Base
$300k
Bonus
Other
$2k
Benefits
$36k
Attorney, Mission-related Investments
Highest Compensated Employee
Median to 75th percentile
$230k
$258k
Base
$207k
Bonus
Other
$1k
Benefits
$13k
Director, Search & Evaluation
Highest Compensated Employee
Median to 75th percentile
$214k
$240k
Base
$180k
Bonus
Other
$3k
Benefits
$23k

Teal figures restate each filed amount in 2026 dollars.

Estimated with New York-Newark-Jersey City, NY-NJ-PA metro-area CPI-U, restating filed pay into May 2026 dollars. A restatement of past pay, not current or projected pay.

Plus 22 unpaid individuals.

Browse compensation in Social Science

Pay in context

Top pay as a share of expenses

In 2023, the highest total compensation at ALZHEIMER'S DRUG DISCOVERY FOUNDATION equaled 1% of the organization's total expenses. The median for social science organizations is 12%.

This organization (2023)
1%
Sector median
12%
Middle half of sector
5% to 24%

Based on 435 social science organizations, each measured at its most recent filing year with reported expenses and compensation.

Funded by

Private foundations whose Form 990-PF Part XV grants matched this organization.

Among peers

Revenue and top compensation, plotted against similar organizations. This organization is highlighted in cyan.

FAQ

Common questions about ALZHEIMER'S DRUG DISCOVERY FOUNDATION

What does the Chief Executive Officer of ALZHEIMER'S DRUG DISCOVERY FOUNDATION earn?

In 2023, the Chief Executive Officer of ALZHEIMER'S DRUG DISCOVERY FOUNDATION received $658,993 in total compensation. This pay is in the top 10% for Chief Executive Officer roles among Social Science organizations nationwide: at least 9 in 10 comparable filings report less. Based on IRS Form 990 data.

How does Chief Executive Officer pay at ALZHEIMER'S DRUG DISCOVERY FOUNDATION compare with similar nonprofits?

Compared with the same role at Social Science organizations nationwide, the 2023 pay of the Chief Executive Officer at ALZHEIMER'S DRUG DISCOVERY FOUNDATION falls in the top 10%. In 2023, the highest total compensation at ALZHEIMER'S DRUG DISCOVERY FOUNDATION equaled 1% of the organization's total expenses. The median for social science organizations is 12%.

What are ALZHEIMER'S DRUG DISCOVERY FOUNDATION's revenue and expenses?

In 2023, ALZHEIMER'S DRUG DISCOVERY FOUNDATION reported $37.7M in total revenue and $61.9M in total expenses on its IRS Form 990.

Free, forever
Build lists. Save your benchmarks.
A free Lucido account lets you build lists of nonprofits and save your search filters. No credit card.
Already a member? Sign in
Build a benchmark

Compare any role, sector, or revenue band

Build your own benchmark from millions of reported positions.